Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
HYAC-UN
Upturn stock ratingUpturn stock rating

HYAC-U (HYAC-UN)

Upturn stock ratingUpturn stock rating
$11
Delayed price
Profit since last BUY1.01%
upturn advisory
Consider higher Upturn Star rating
BUY since 35 days
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

03/27/2025: HYAC-UN (1-star) has a low Upturn Star Rating. Not recommended to BUY.

Upturn Star Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

AI Based Fundamental Rating

ratingratingratingratingrating

Above Average Performance

These Stocks/ETFs, based on Upturn Advisory, frequently surpass the market, reflecting reliable and trustworthy advice.

Analysis of Past Performance

Type Stock
Historic Profit -1.69%
Avg. Invested days 71
Today’s Advisory Consider higher Upturn Star rating
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 4.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 03/27/2025

Key Highlights

Company Size ETF
Market Capitalization 0 USD
Price to earnings Ratio -
1Y Target Price -
Price to earnings Ratio -
1Y Target Price -
Volume (30-day avg) 99
Beta -
52 Weeks Range 10.46 - 14.70
Updated Date 03/30/2025
52 Weeks Range 10.46 - 14.70
Updated Date 03/30/2025
Dividends yield (FY) -
Basic EPS (TTM) -

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -
Operating Margin (TTM) -

Management Effectiveness

Return on Assets (TTM) -0.24%
Return on Equity (TTM) -

Valuation

Trailing PE -
Forward PE -
Enterprise Value 325322464
Price to Sales(TTM) -
Enterprise Value 325322464
Price to Sales(TTM) -
Enterprise Value to Revenue -
Enterprise Value to EBITDA -
Shares Outstanding -
Shares Floating 22286277
Shares Outstanding -
Shares Floating 22286277
Percent Insiders -
Percent Institutions 1.46

Analyst Ratings

Rating -
Target Price -
Buy -
Strong Buy -
Buy -
Strong Buy -
Hold -
Sell -
Strong Sell -
Strong Sell -

ai summary icon Upturn AI SWOT

HYAC-U

stock logo

Company Overview

History and Background

HYAC-U represents the units of Health Assurance Acquisition Corp. 1, a blank check company (SPAC) formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses.

Core Business Areas

  • SPAC Formation: Health Assurance Acquisition Corp. 1's primary function is as a special purpose acquisition company. It exists solely to identify and merge with an existing private company, effectively taking that company public.

Leadership and Structure

Since it is a SPAC, its leadership typically consists of experienced investors and dealmakers who seek out suitable acquisition targets. The structure is temporary, designed to facilitate a merger rather than long-term corporate governance.

Top Products and Market Share

Key Offerings

  • SPAC Units: HYAC-U offers units, each containing shares of common stock and warrants. The 'product' is the opportunity for investors to participate in the potential upside of the acquired company after a merger. Market share is irrelevant for SPAC units themselves; value is determined by the quality of the merger target. Competitors are other SPACs.

Market Dynamics

Industry Overview

The SPAC market is dynamic and often volatile. It's influenced by investor sentiment, regulatory changes, and overall market conditions. SPACs offer an alternative route to public markets for companies, but carry risks related to deal sourcing and execution.

Positioning

HYAC-U aims to identify and merge with a high-growth healthcare or healthcare-related company. Its success depends on identifying an attractive target and successfully negotiating a merger agreement.

Total Addressable Market (TAM)

The TAM for healthcare companies seeking to go public is substantial, potentially encompassing hundreds of billions of dollars. HYAC-U's position depends on its ability to identify and secure a valuable slice of this TAM through a successful merger.

Upturn SWOT Analysis

Strengths

  • Experienced Management Team (in deal-making)
  • Capital Raised for Acquisition
  • Focus on Healthcare Sector

Weaknesses

  • Dependence on Finding Suitable Target
  • Dilution Potential from Warrants
  • Limited Operating History

Opportunities

  • Growing Demand for Healthcare Services
  • Innovation in Healthcare Technology
  • Potential for High Returns from Successful Merger

Threats

  • Competition from Other SPACs
  • Unfavorable Market Conditions
  • Regulatory Changes
  • Failure to Find Suitable Target

Competitors and Market Share

Key Competitors

  • DNAC
  • SVOK
  • ARTE

Competitive Landscape

The 'market share' of SPACs is not conventionally defined since their value is derived from the target they eventually acquire. Competition is fierce in finding attractive targets.

Major Acquisitions

Growth Trajectory and Initiatives

Historical Growth: No historical growth as a SPAC.

Future Projections: Future growth depends entirely on the acquired company's growth prospects.

Recent Initiatives: Focus is on identifying and evaluating potential merger targets.

Summary

HYAC-U is a SPAC seeking to merge with a company in the healthcare space. Its strength lies in its management team's expertise in deal-making and the capital it has raised. Its success hinges on finding a suitable target, and investors face the risk of dilution and market volatility. The company needs to carefully evaluate potential targets and negotiate favorable terms to deliver shareholder value.

Similar Companies

  • DNAC
  • SVOK
  • ARTE

Sources and Disclaimers

Data Sources:

  • SEC filings, Company press releases, Financial News Outlets

Disclaimers:

This analysis is based on publicly available information and is for informational purposes only. It is not financial advice. Investing in SPACs carries inherent risks.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About HYAC-U

Exchange NYSE
Headquaters New York, NY, United States
IPO Launch date 2023-07-26
CEO, CFO, Secretary & Chairman Mr. Christopher Bradley
Sector Financial Services
Industry Shell Companies
Full time employees -
Full time employees -

Haymaker Acquisition Corp. 4 does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or other business combination with one or more businesses or entities. It intends to acquire and operate business in the consumer and consumer-related products and services industries. The company was incorporated in 2023 and is based in New York, New York.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​